US Task Force: Ashkenazi Jewish Women Should Test For Breast Cancer Genes
Graphic by Angelie Zaslavsky
(JTA) — Ashkenazi Jewish women should be screened for the BRCA1 and BRCA2 genes linked to breast cancer.
That’s the recommendation by a U.S. task force announced in an editorial this week in the Journal of the American Medical Association.
One in 40 Ashkenazi Jews have a BRCA1 or BRCA2 mutation, compared with one in 300 people in the general population, according to studies.
The U.S. Preventative Services Task Force says that primary care doctors should assess women’s BRCA1 and BRCA2 mutation risks) if their ancestry is prone to BRCA mutations, such as Ashkenazi Jewish women, and if they previously were treated for breast or ovarian cancer.
The editorial also said that “researchers are actively reporting higher BRCA1 and BRCA2 mutation frequencies across diverse populations than previously realized.”
It also called for an increase in the number of cancer-specific genetic counselors in the United States.
The editorial was co-authored by Dr. Susan Domchek, executive director of the Basser Center for BRCA at the Abramson Cancer Center at the University of Pennsylvania, and Dr. Mark Robson, a medical oncologist and chief of Breast Medicine Service at Memorial Sloan Kettering Cancer Center.
This is a moment of great uncertainty. Here’s what you can do about it.
We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news this Passover. All donations are being matched by the Forward Board - up to $100,000.
This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.
With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give this Passover is invested in the future of the Forward — and telling the American Jewish story fully and fairly.
The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.
Support our mission to tell the Jewish story fully and fairly.
